1.Diagnostic value of non-invasive cardiac output parameters in premature infants with patent ductus ;arteriosus
Huan LI ; Yingji ZHANG ; Chuanzhong YANG ; Lin YI ; Huitao LI ; Peng HUANG ; Yanqing LIN ; Hui TANG
Chinese Journal of Perinatal Medicine 2016;19(5):371-376
Objective To investigate the diagnostic value of non-invasive cardiac output parameters:cardiac index (CI) and minute distance (MD), in premature infants with patent ductus arteriosus (PDA) and determine the cut-off value. Methods Clinical data of 98 premature infants admitted to the neonatal intensive care unit from January 2015 to June 2015 were collected. These premature infants were divided into the treated PDA group (n=30),the untreated PDA group (n=28) and the normal premature group (n=40) based on the results of echocardiogram in the first three days after birth and the use of drugs. Non-invasive cardiac output parameters were measured in the first three days after birth. The data were analyzed by t test, analysis of variance and SNK-q test. The diagnostic value of CI and MD for PDA was analyzed by the receiver operating characteristic curve. Results By preliminary analysis of the ROC curve,CI and MD were the most representative parameters for the diagnosis of PDA which need to be treated clinically, we thus chose CI and MD in this study. The aortic and pulmonary arterial CI and MD in the treated PDA group were significantly higher than in the untreated PDA group and the normal premature group (all P<0.05). There were no significant differences between the untreated PDA group and the normal premature group in the aortic and pulmonary arterial CI and MD (all P>0.05). The cut-off value of the aortic CI and MD was 2.95 L/(min·m2) and 21.50 m/min, respectively, while that of the pulmonary arterial CI and MD was 4.55 L/(min·m2) and 26.50 m/min, respectively. The sensitivity and specificity of the combined aortic CI and MD for the treated PDA group were 0.90 and 0.82, and those of combined pulmonary arterial CI and MD were 0.87 and 0.82;and those of combined aortic and pulmonary arterial CI and MD were 0.80 and 0.88, respectively. Conclusions The non-invasive cardiac output parameters CI and MD have good diagnostic value for the PDA needing clinical treatment, and the combined use of the two parameters can improve specificity, and help formulate the early treatment strategy for premature infants with PDA. When aortic CI was ≥ 2.95 L/(min·m2) and MD was ≥ 21.50 m/min, a preliminary diagnosis of the PDA needing clinical treatment, can be made, and simultaneously when the pulmonary arterial CI was ≥4.55 L/(min·m2) and MD was≥26.50 m/min, the arterial duct should be closed timely.
2.A case-control study on the relationship among indoor air pollution,depression and oncogenesis of lung cancer.
Xiwen SUN ; Xudong DAI ; Yubo SHI ; Yingji LIN
Chinese Journal of Lung Cancer 2002;5(2):101-103
BACKGROUNDTo evaluate the relationship among indoor air pollution, depression and oncogenesis of lung cancer.
METHODSAn 1:3 matched case-control study was carried out. Conditional logistic regression was applied to process the data.
RESULTSAfter some confounding factors were adjusted, the ORs increased 122% and 113% for the amount of coal using ≥46kg/m² and heating by coal stove respectively. The ORs elevated more than five-folds for disharmony and rupture of marriage, difference of accommodation and acclimation by oneself and human relationship respectively. The risk of lung caner obviously increased for frequent exposure to indoor cooking smoke combinated with depressed mood or mental scar respectively.
CONCLUSIONSThe indoor air pollution, depression and mental scar are important factors of oncogenesis of lung cancer.
3.The morbidity and mortality trend and prediction of lung cancer in residents of Nangang District of Harbin in China during the past 10 years.
Xiwen SUN ; Wei LIU ; Shuling WU ; Huili HAN ; Yingji LIN ; Xudong DAI
Chinese Journal of Lung Cancer 2005;8(6):514-517
BACKGROUNDIt is not clear yet about the secular changes of morbidity and mortality trend of lung cancer in residents of Nangang District of Harbin in China. The aim of this study is to estimate the trend of lung cancer morbidity and mortality in residents of Nangang District from 1992 to 2001 and to predict their levels in the future 5 years.
METHODSData were collected from the annual statistic reports on cancer death cause from Nangang District in Harbin. The classification of death cause was made according to the ICD-9. Predictions about morbidity and mortality were made by the gray system GM(1,1).
RESULTSDuring the past 10 years, the morbidity and mortality of lung cancer were placed in uptrend slowly. The average morbidity and mortality of lung cancer were 44.75 per 100000 and 41.37 per 100000 respectively, and lung cancer was the first leading cancer for both episode and death of malignant tumors. The proportions of lung cancer were 25.91% and 33.29% for episode and death in all malignant tumors respectively. A half patients with lung cancer was 20-64 years old. Predictive morbidity and mortality of lung cancer would be 47.79/100000 and 44.81/100000 for men and 45.80/100000 and 42.02/100000 for women respectively.
CONCLUSIONSThe morbidity and mortality of lung cancer show a slowly increasing trend. Lung cancer is one of main malignant tumors among people of 20-64 years old. The gradually aging population, environmental pollution and individual unhealthy living habits are the important factors of lung cancer increasing.
4.Discussion of the 8 th edition of AJCC/UICC staging system from the clinical stage Ⅲ nasopharyngeal carcinoma
Yingji HONG ; Mei LI ; Zhining YANG ; Yajie XUE ; Xiaoying GAO ; Zhixiong LIN
Chinese Journal of Radiation Oncology 2020;29(10):822-826
Objective:To evaluate the 8 th edition of AJCC/UICC staging system for stage Ⅲ nasopharyngeal carcinoma (NPC) by the survival analysis. All patients were treated with intensity-modulated radiotherapy (IMRT). Methods:Among 1351 treatment-na?ve NPC patients who received radiotherapy/chemoradiotherapy in our hospital from December 2008 to October 2014, 742 and 784 cases were classified as clinical stage Ⅲ based on the criteria of the 7 th and 8 th edition of AJCC/UICC staging systems, respectively. These patients were classified into three subgroups according to the 7 th and 8 th edition of AJCC/UICC staging systems: T 3N 0-1 as G 1( n=226, n=245), T 1-2N 2 as G 2( n=180, n=187) and T 3N 2 as G 3( n=336, n=352). The 5-year overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional recurrence-free survival (LRRFS) were analyzed with Kaplan- Meier method. The differences among different groups were evaluated by log-rank test. Results:There were 93.6% patients evaluated by the 8 th AJCC/UICC staging system remained the same cohort with those by the 7 th AJCC/UICC staging system. The 5-year OS, PFS, DMFS and LRRFS of the 8 th and 7 th staging systems were 84.8% and 85.4%, 76.2% and 77.0%, 80.4% and 81.3%, 89.8% and 90.6%, respectively (all P>0.05). The OS, PFS or DMFS significantly differed among three subgroups classified by the 8 th staging system (all P<0.001). In addition, statistical significance was observed between G 1 and G 2, and between G 1 and G 3(both P<0.05), whereas no statistical significance was noted between G 2 and G 3( P=0.183, 0.310, 0.248). Conclusions:The distribution features and clinical endpoints of clinical stage Ⅲ defined by the 8 th AJCC/UICC staging system are similar to those defined by the 7 th AJCC/UICC staging system. The distribution of survival risk significantly differs among different subgroups. N 2 plays a major role in assessing the survival risk of patients with stage Ⅲ NPC. In the era of IMRT plus chemotherapy, the effect of local tumors on clinical prognosis has been diminished. The 8 th AJCC/UICC staging system remains to be further improved.
5.Safety risk assessment of in vitro heart in antitumor drug development
Shuangjia ZHENG ; Ting ZHAO ; Cuixia REN ; Baoqiang WANG ; Lanlan CHEN ; Moxu LIN ; Yingji LI ; Xu ZHANG
Chinese Journal of Tissue Engineering Research 2024;28(27):4265-4272
BACKGROUND:Tyrosine kinase inhibitors,as well as other types of small-molecule cancer drugs,can cause severe cardiotoxicity. OBJECTIVE:To perform a heart safety re-evaluation by observing the effects of antitumor drugs on isolated heart electrocardiograph,cardiac action potential and associated ion channels and cytotoxicity. METHODS:Extracorporeal cardiac perfusion was given to the isolated rabbit heart using Langendorff perfusion:Sunitinib(0.3,3,10 μmol/L),Crizotinib(0.3,1,3 μmol/L),and Doxorubicin(1,30 μmol/L)were perfused sequentially for 120 minutes to record electrocardiograph and left ventricular pressure.A blank control group was set for comparison.Manual patch clamp was used to record the effects of Crizotinib,Sunitinib,Doxorubicin on hERG,Cav1.2,Nav1.5 channel currents and action potential in human induced pluripotent stem cell derived cardiomyocytes.Adenosine triphosphate level in human induced pluripotent stem cell derived cardiomyocytes was detected by CellTiter-Glo luminescent cell viability assay. RESULTS AND CONCLUSION:Isolated rabbit heart using Langendorff perfusion:Compared with the blank ontrol group,Sunitinib and Crizotinib at≥3 μmol/L decreased heart rate(P<0.01)and prolonged QT/QTc interval(P<0.01),and reduced left ventricular pressure to different extents.Manual patch clamp recording:Compared with the blank control group,Sunitinib and Crizotinib at 3 μmol/L inhibited the activities of hERG,Nav1.5 and Cav1.2 channels and significantly prolonged the duration of action potential(P<0.01).According to the analysis of the test article,the difference between the labeled concentration and the measured concentration of the recovered solution was not significant.Cell viability assays:Compared with the blank control group,adenosine triphosphate content in human induced pluripotent stem cell derived cardiomyocytes significantly decreased after treatment with Sunitinib(IC50=4.64 μmol/L),Doxorubicin(IC50=4.21 μmol/L)and Crizotinib(IC50=2.87 μmol/L),indicating that cell viability significantly decreased(P<0.01).To conclude,this study successfully established an early cardiac safety evaluation method for antitumor drugs,which provides good support and help for the subsequent development of antitumor drugs.